Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study.
Seung Mi LeeGeum Joon ChoWon Young WiErrol R NorwitzBo Kyung KooJeesun LeeYoung Mi JungSoo Heon KwakChan-Wook ParkJong Kwan JunSae Kyung JooMin-Jeong OhWon KimJoong Shin ParkPublished in: Hepatology international (2022)
Any form of FLD is a risk factor for adverse pregnancy outcomes. These data suggest that MAFLD is associated with a higher risk of adverse pregnancy outcomes for both mother and fetus than NAFLD.